Floatz logo

MERCAPTOPURINE ANHYDROUS

Adult Acute Lymphocytic Leukemia

Shanxi Bethune HospitalSmall moleculePhase 4 / ApprovedActive
A
81/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
75/ 100
Competitive Position
89/ 100

Competitive context

73 Active assets in the Adult Acute Lymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Shanxi Bethune Hospital
Phase 4BBB
Cyclophosphamide
The First Affiliated Hospital of Zhengzhou University
Phase 4BBB
Cytosin-Arabinosid
PETHEMA Foundation
Phase 4BBB
METHOTREXATE
PETHEMA Foundation
Phase 4BBB
VINDESINE
Shanxi Bethune Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

MERCAPTOPURINE ANHYDROUS is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative ·
80 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
75 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →